Swedish Vascular Registry. Outcomes of endovascular abdominal aortic aneurysm repair compared with open surgical repair in high-risk patients: results from the Swedish Vascular Registry

Department of Vascular Surgery, Karolinska University Hospital, Stockholm, Sweden.
Journal of vascular surgery: official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter (Impact Factor: 3.02). 10/2008; 48(6):1382-8; discussion 1388-9. DOI: 10.1016/j.jvs.2008.07.009
Source: PubMed


The management of infrarenal aortic aneurysms in high-risk patients remains a challenge. Endovascular aneurysm repair (EVAR) is associated with superior short-term mortality rates but unclear long-term results and has not been shown to improve survival in patients unfit for open repair (OR). The aim of this population-based study was to evaluate the outcome after elective EVAR compared with OR in a high-risk patient cohort.
Prospectively collected data from January 2000 to December 2006 were retrieved from the Swedish Vascular Registry. The high-risk cohort was defined as age >or=60 years, American Anesthesiologists Association (ASA) class 3 or 4, and at least one cardiac, pulmonary, or renal comorbidity. These criteria were met by 217 of 1000 EVAR patients and 483 of 2831 OR patients. Primary end points were 30-day and 1-year all-cause mortality. Kaplan-Meier curves for survival and multivariate Cox regression analyses were performed.
The crude 30-day and 1-year all-cause mortality rates for EVAR vs OR for the whole treatment group (n = 3831) were 1.8% vs 2.8% and 8.0% vs 7.2%, respectively. In the high-risk cohort (n = 700), EVAR patients were approximately 2 years older and renal insufficiency and diabetes mellitus were more common, and smoking was more prevalent in the OR group. About two-thirds of EVAR procedures were performed at university hospitals and one-half of OR procedures were performed at county hospitals. In the high-risk cohort, there was no difference in mortality at 30-days (EVAR, 4.6% vs OR, 3.3%), but OR had lower 1-year mortality (8.5% vs 15.9%; P = .003). More bleeding complications occurred in the EVAR group, but more pulmonary complications occurred in the OR group; however, there was no difference in cardiac, cerebrovascular, or renal complications. The mean follow-up was 3.4 years. EVAR was associated with increased mortality risk after adjusting for age, ASA class, and comorbidities (hazard ratio, 1.50; 95% confidence interval, 1.07-2.12; P = .02). Kaplan-Meier survival analysis showed a lower mortality rate for patients undergoing OR, which remained during follow-up (P = .001).
Elective OR of aortic aneurysms seems to have a better outcome compared with EVAR in this specific, population-based, high-risk patient cohort after adjusting for covariates. We cannot confirm the benefit of EVAR from previous registry studies with a similar high-risk definition. In clinical practice, OR may be at least as good as EVAR in high-risk patients fit for surgery.

Download full-text


Available from: Jonas Malmstedt, Oct 10, 2015
18 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Summary Endovascular abdominal aortic aneurysm repair (EVAR) has become an alternative method to open surgical repair of abdominal aortic aneurysm (AAA) since the early 90’s. In our center this method was used in 2003 for the first time. Aim of the Study: The aim of the single-center study is to evaluate 30 days and 1 year outcomes of EVAR of abdominal aortic aneurysm in the years 2003–2008. Materials and Methods: Between January 2003 and December 2008, 172 patients who had undergone elective EVAR were retrospectively analyzed. The interdisciplinary consensus among angiologist, interventional radiologist and vascular surgeon was reached to repair the aneurysm by EVAR. All patients underwent preoperative contrast-enhanced computed tomography (CT) to evaluate AAA anatomy. Tortuous iliac artery in CT was an indication to arteriography. Follow-up investigation included a clinical examination at 3, 6 and 12 months, duplex ultrasound scanning was performed at 3 and 6 months. Computed tomography (CT) scans were always performed at 1 and 12 months and in case of any abnormality on the duplex ultrasound scanning. Results: Stentgraft implantation was successful in 168 (97.5 %) of 172 attempted cases. 2 patients died because of circulatory insufficiency. 1 patient required conversion and 1 patient iliaco-iliaco bypass because of inability to deploy the stentgraft. Early complications included deaths and intraoperative device-related problems. There were 26 early complications (15 %) defined as occurring within 30 days after surgery. 12 months after the primary operation the control tests were carried out among 142 patients (82.5 %). There were 22 late complications among 142 patients, who received full followup. 7 patients died from unknown reasons. The hospital has lost track of other 30 patients. Conclusion: The method of endovascular technology is a technique to save lives of patients suffering from serious comorbidities. However, it is crucial to develop other, more effective methods in order to decrease the number of early and late complications. Zusammenfassung Die endovaskuläre Aneurysmatherapie stellt eine Alternative zum konventionellen Verfahren bei Bauchaortenaneurysma (BAA) dar. In unserem Krankenhaus wurde diese Methode zum ersten Mal im Jahr 2003 angewendet. Ziel: Das Ziel unserer Untersuchung war die Beurteilung der Ergebnisse der endovaskulären Aneurysmatherapie in 2003–2008 nach 30 Tagen und einem Jahr. Material und Methoden: Vom Januar 2003 bis Dezember 2008 erhielten 172 Patienten mit einem BAA gemeinsam durch Angiologen, Radiologen und Gefäßchirurgen eine endovaskuläre Aneurysmatherapie. Alle Patienten erhielten präoperativ eine Kontrastmittel-Computertomographie. Eine geschlängelte A. iliaca externa verlangte eine Angiographie. Die Funktion der Stentprothese wurde nach 3, 6 und 12 Monaten durch klinische Untersuchung, nach 3 und 6 Monaten durch eine Duplexsonographie und nach einem und 12 Monaten durch ein CT weiter kontrolliert. Auch bei Abnormalitäten in der Duplexsonographie wurde ein CT durchgeführt. Ergebnisse: Bei 168 Patienten von 172 Patienten (97,5 %) war die Stentimplantation erfolgreich. Zwei Patienten verstarben an Kreislaufinsuffizienz. Ein Patient verlangte eine Konversion zur chirurgischen Therapie und ein Patient einen iliakoiliakalen Bypass, weil sich bei ihm der kurze kontralaterale Schenkel nicht entfaltete. Frühkomplikationen berücksichtigten Todesfälle und intraoperative prothesenspezifische Komplikationen. Es waren 26 Frühkomplikationen (15 %), definiert als Komplikationen innerhalb von 30 Tagen, zu verzeichnen. Zwölf Monate nach der primären Operation hatten wir Kontakt mit 142 Patienten (82,5 %), bei denen 22 Spätkomplikationen aufgetreten waren. Sieben Patienten verstarben an unklarer Ursache. Schlussfolgerung: Die endovaskuläre Aneurysmatherapie ist eine lebensrettende Technik für Hochrisikopatienten. Allerdings ist es notwendig, noch bessere Methoden zu entwickeln, um die Anzahl der Komplikationen zu reduzieren.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: First Page of the Article
    Computer Applications in Medical Care, 1983. Proceedings. The Seventh Annual Symposium on; 02/1983
  • [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate the success of endoleak repair using translumbar (TL) endoleak embolization compared with a transarterial (TA) technique that involves embolization of the endoleak cavity itself in addition to the feeding artery. Eighty-four patients (mean age, 78.2 years; age range, 58-94 years) with type 2 endoleaks were included in this retrospective study. Patients underwent either TL endoleak embolization or TA embolization between January 2002 and December 2007. TA embolization involved entering the endoleak cavity through the inferior mesenteric or lumbar artery. Both the endoleak cavity and the feeding artery were then embolized by using coils through a microcatheter. TL embolizations were performed by using standard technique with coils and n-butyl cyanoacrylate as the embolization agents. Clinical success was defined as the absence of an endoleak and/or aneurysm enlargement at follow-up CT angiography. Statistical comparison was performed with the Fisher exact test. Endoleak repair was successful in 72% (45/62) of the TL embolizations and 78% (18/23) of the TA embolizations, with a mean follow-up of 18.7 months (range, 1-84 months). There was no significant difference in clinical success between the two groups (P = .41). There were two (3.2%) complications in the TL group and no complications in the TA group. The effectiveness of the TA endoleak embolization technique, which involves embolizion of the endoleak cavity and the feeding artery, is similar to that of TL embolization for treatment of type 2 endoleaks.
    Journal of vascular and interventional radiology: JVIR 09/2009; 20(10):1299-302. DOI:10.1016/j.jvir.2009.07.003 · 2.41 Impact Factor
Show more